Oberg Ann L, McKinney Brett A, Schaid Daniel J, Pankratz V Shane, Kennedy Richard B, Poland Gregory A
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Tandy School of Computer Science, Department of Mathematics, University of Tulsa, Tulsa, OK, USA.
Vaccine. 2015 Sep 29;33(40):5262-70. doi: 10.1016/j.vaccine.2015.04.088. Epub 2015 May 6.
The field of vaccinology is increasingly moving toward the generation, analysis, and modeling of extremely large and complex high-dimensional datasets. We have used data such as these in the development and advancement of the field of vaccinomics to enable prediction of vaccine responses and to develop new vaccine candidates. However, the application of systems biology to what has been termed "big data," or "high-dimensional data," is not without significant challenges-chief among them a paucity of gold standard analysis and modeling paradigms with which to interpret the data. In this article, we relate some of the lessons we have learned over the last decade of working with high-dimensional, high-throughput data as applied to the field of vaccinomics. The value of such efforts, however, is ultimately to better understand the immune mechanisms by which protective and non-protective responses to vaccines are generated, and to use this information to support a personalized vaccinology approach in creating better, and safer, vaccines for the public health.
疫苗学领域正日益朝着生成、分析和建模极其庞大且复杂的高维数据集的方向发展。我们已在疫苗组学领域的发展和进步中使用了此类数据,以实现对疫苗反应的预测并开发新的候选疫苗。然而,将系统生物学应用于所谓的“大数据”或“高维数据”并非没有重大挑战,其中最主要的挑战是缺乏用于解释数据的金标准分析和建模范式。在本文中,我们讲述了过去十年在疫苗组学领域处理高维、高通量数据过程中所学到的一些经验教训。然而,此类努力的价值最终在于更好地理解产生对疫苗的保护性和非保护性反应的免疫机制,并利用这些信息支持个性化疫苗学方法,从而为公共卫生制造出更好、更安全的疫苗。